Biomet Hip Replacements
Hill, Peterson, Carper, Bee & Deitzler, PLLC, is now accepting cases related to Biomet Inc. and its subsidiaries concerning their M2a Magnum hip implants.
Biomet is based in Warsaw, Indiana. It reported sales of over $2.5 billion dollars in 2011, with much of its revenue generated by its sale of knee and hip implants.
On March 26, 2012, the Securities and Exchange Commission (SEC) charged Biomet Inc. with violating the Foreign Corrupt Practices Act when its subsidiaries and agents bribed public doctors employed by public hospitals in Argentina, Brazil and China for nearly a decade to win business. Click here to view the entire SEC complaint.
The Biomet M2a Magnum hip is an all-metal (metal-on-metal) hip implant which was approved by the Food and Drug Administration (FDA) in 2004. Marketed primarily for younger and more active individuals and allegedly designed to last 15 years or more, reports of failure within a few years are increasing at an alarming rate.
In 2009, the FDA reportedly received 11 adverse event reports involving the Biomet M2A Magnum. In 2011 alone, the FDA received 80 adverse event reports for this device – nearly an eight-fold increase.
Metal-on-metal hip replacement devices have been associated with many serious problems, including acetabular cup loosening, bone loss, chronic pain, and metallosis.
The Biomet Magnum hip replacement contains chromium and cobalt in both the femoral head and acetabular cup. When these two surfaces rub against each other, tiny fragments of metal can be sloughed off into the blood system and surrounding tissue causing "metallosis" also known as metal poisoning. In addition, the premature failures of these devices have resulted in the need for many patients to undergo additional revision surgery to remove and replace the implant.
If you or a loved one has experienced problems related to the Biomet Hip Replacement, please contact us as soon as possible for a free and confidential case evaluation.
It is important that you contact an experienced attorney who specializes in cases where defective medical devices are concerned. Our experience with DePuy and Pinnacle Hip Implants along with Guidant and Medtronic defibrillator implant litigation and cases involving numerous drug manufacturers has given us the insight that we need to be effective litigators for consumers with defective medical devices. The experienced group of attorneys at Hill, Peterson, Carper, Bee & Deitzler will provide you with individual attention and work for you to obtain the compensation that you deserve.